HIGHLIGHTS
- who: Hadi Hassannia et al. from the Immunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari POBox, Iran have published the paper: Preclinical Assessment of Immunogenicity and Protectivity of Novel ROR1 Fusion Proteins in a Mouse Tumor Model, in the Journal: Cancers 2022, 5827 of /2022/
- what: This study aimed to produce and evaluate different fusion proteins of mouse (mROR1) to enhance immunogenicity and protective efficacy of Four fusion proteins composed of extracellular region of mROR1 immunogenic fragments of TT as well as Fc region of mouse IgG2a were produced and employed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.